Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

The main symptom of generalized anxiety disorder is excessive worry for at least 6 months. It's often caused by genetic, ...

A first-of-its-kind Canadian trial is testing psilocybin, the psychedelic component found in magic mushrooms, on participants ...

A clinical LSD formulation shows promise for severe anxiety. Trials reveal meaningful symptom relief and limited side effects ...

This anxiety test is based on the GAD-7, which doctors use to screen for anxiety disorders. Take the test and get your ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point ...

A mobile app can improve the symptoms of one of the commonest mental health problems in students—even with limited engagement ...

Two new studies are helping to shed light on the extent Canadians feel climate change is impacting their mental health.

But 2.35 per cent had "clinically relevant" symptoms.

LifeStance Health reports Xanax provides quick anxiety relief but is not suitable for long-term use; alternatives and therapy ...

We can ease our travel anxieties by understanding what underlies them and what we bring to travel from our particular ...

The Kingston Health Sciences Centre Research Institute launched the first-ever Health Canada-approved clinical trial ...